| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.0M | -62.8% |
| Cost of Revenue | $58.2M | -38.1% |
| Gross Profit | -$4.2M | -108.1% |
| R&D Expense | $9.9M | +3.8% |
| SG&A Expense | $21.1M | -26.9% |
| Operating Income | -$52.0M | -528.4% |
| Pre-tax Income | -$62.6M | -7304.6% |
| Income Tax | $103K | -25.4% |
| Net Income | -$62.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.7M | +166.7% |
| Short-term Investments | $8.2M | -69.6% |
| Accounts Receivable | $8.0M | +16.2% |
| Inventory | $22.0M | -64.2% |
| Current Assets | $53.4M | -49.0% |
| Total Assets | $72.9M | -42.9% |
| Current Liabilities | $17.1M | -35.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.4M | +66.8% |
| Capital Expenditures | $1.3M | -39.2% |
| Investing Cash Flow | $19.8M | +163.9% |
| Financing Cash Flow | -$61K | -100.2% |
| Free Cash Flow | -$13.6M | +65.3% |
| -6276.6% |
| EPS (Basic) | -$1.04 | -1200.0% |
| EPS (Diluted) | -$1.04 | -642.9% |
| Long-term Debt |
| $50.0M |
| +0.0% |
| Total Liabilities | $64.5M | -0.7% |
| Stockholders' Equity | $8.4M | -86.7% |